Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases

Clinical trial NCT05768490 · RECRUITING

Trial details

NCT number: NCT05768490
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Brain Metastases Radiotherapy EGFR Activating Mutation

Start date: 2023-03-15
Primary completion: 2028-12-31
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.